Optimization of Antimicrobial Stewardship Programs Using Therapeutic Drug Monitoring and Pharmacokinetics-Pharmacodynamics Protocols: A Cost-Benefit Review.

One of the great challenges of antimicrobial stewardship programs is to demonstrate cost-benefit advantages of the implemented measures. Our group, led by infectologists João Telles (PhD) and Felipe Tuon (PhD), demonstrated in a recent review that serum dosages of antimicrobials guided by protocols and empirical prescriptions directed by PK/PD, improve cost-effectiveness and decrease hospital expenses

Referência: João Paulo Telles, Ronaldo Morales, Carolina Hikari Yamada, Tatiana A. Marins, Vanessa D’Amaro Juodinis, Jaques Sztajnbok, Moacyr Silva, Bil Randerson Bassetti, James Albiero, and Felipe Francisco Tuon. Ther Drug Monit. 2023 Jan 3. doi: 10.1097/FTD.0000000000001067

https://pubmed.ncbi.nlm.nih.gov/36622029

CLICK HERE

Facebook
Twitter